Clinical Trials Directory

Trials / Completed

CompletedNCT03172221

Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant Women

Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women

Status
Completed
Phase
Study type
Observational
Enrollment
880 (actual)
Sponsor
Foundation for Innovative New Diagnostics, Switzerland · Academic / Other
Sex
Female
Age
15 Years
Healthy volunteers

Summary

This is a cross-sectional and multicentre clinical trial to study the performance of the Histidine Rich Protein 2 (HRP2) highly sensitive rapid diagnostic test (HS-RDT) for the detection of malaria during pregnancy in low transmission settings from Colombia and Indonesia. The new HS-RDT will be compared with conventional good quality RDTs, microscopy, and NAATs \[loop-mediated isothermal amplification (LAMP), nested PCR (nPCR)\], in peripheral blood samples with quantitative reverse transcription PCR (qRT-PCR) as reference standard.

Detailed description

The activities proposed will be performed in the context of health centres receiving pregnant women for antenatal care visit. Finger-prick blood (300 µL) will be collected and used to test for malaria with the HS-RDT, as well as with conventional good quality RDTs, microscopy and local NAATs (LAMP and nPCR). Dried blood spots will also be collected for qRT-PCR testing. Patient information (demographics, obstetric history, malaria prevention measures, etc.) as well as laboratory results will be recorded and entered into a dedicated database.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHS-RDTA single finger-prick blood sample will be collected and used to test participants with the HS-RDT. The results of the results of the test will not be used for treatment purposes nor used to inform patient care.

Timeline

Start date
2017-07-25
Primary completion
2018-01-31
Completion
2018-01-31
First posted
2017-06-01
Last updated
2023-11-30

Locations

2 sites across 1 country: Colombia

Source: ClinicalTrials.gov record NCT03172221. Inclusion in this directory is not an endorsement.